Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma
Authors:
- Dong Goo KimDKDong Goo Kim
- In Sung MoonIMIn Sung Moon
- Myung Duk LeeMLMyung Duk Lee
- Jung Hyun ParkJPJung Hyun Park
- 18 December 2009
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 101 (1) , 47-53
Abstract
Purpose: Liver resection (LR) and liver transplantation (LT) are considered the only two potentially curative treatments for hepatocellular carcinoma (HCC). Recently, there has been an intense debate as to whether LR or LT is the optimal initial treatment for patients with Child A or B cirrhosis. The aim of this study was to compare the results of LR and LT in patients with HCC and with Child A or B cirrhosis in a single center over a 10‐year period.Method: Seventy‐eight patients were treated with LT and 130 were treated with LR. We evaluated patient characteristics, short‐term results such as hospital stay, postoperative complication, mortality, and long‐term results such as overall and recurrence‐free survival and recurrence.Results: The hospital stay of the LT group was significantly longer than that of the LR group (P < 0.001). The postoperative complication rate and the early operative mortality rate were similar between the two groups. The overall survival rate was higher after LT than it was after LR, but not to a statistically significant degree (P = 0.267). The recurrence‐free survival rate was significantly higher after LT than it was after LR (P = 0.002). Within and beyond the Milan criteria, the overall survival rate was higher after LT than it was after LR, but not to a statistically significant degree. The recurrence‐free survival rate was significantly higher after LT than it was after LR in the patients within Milan criteria (P < 0.001). HCC recurred more frequently after resection (51.5%) than it did after transplantation (29.5%) (P < 0.001), and HCC recurrence developed in the liver more frequently after LR than it did after LT (P = 0.002). However, after recurrence, LR had better survival than LT did, but not to a statistically significant degree (P = 0.177).Conclusion: LT should be considered as the primary treatment in patients with HCC within the Milan criteria. LR is recommended for patients with HCC beyond the Milan criteria. The LT group showed a significantly lower recurrence rate than the LR group. However, in the case of recurrence, the LT group showed a poorer long‐term outcome than the LR group. J. Surg. Oncol. 2010;101:47–53.Keywords
This publication has 33 references indexed in Scilit:
- Treatment of hepatocellular carcinomaCritical Reviews in Oncology/Hematology, 2006
- Improved Long‐term Survival after Liver Resection for Hepatocellular Carcinoma in the Modern Era: Retrospective Study from HCV‐endemic AreasWorld Journal of Surgery, 2006
- Resection, Transplantation, Either, or Both? Other Pieces of the PuzzleLiver Transplantation, 2005
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Liver transplantation for hepatocellular carcinomaGastroenterology, 2004
- Liver transplantation for hepatocellular carcinomaBritish Journal of Surgery, 2004
- Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantationHepatology, 1999
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996
- Liver transplantation for hepatocellular carcinomaWorld Journal of Surgery, 1995
- Role of Liver Transplantation in Cancer TherapyAnnals of Surgery, 1985